Indications and uses
For the treatment of acne.
For the treatment of acne.
cover the entire affected area with a think layer and rinse thoroughly one to three times daily because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day.
may stain or damage some fabrics, materilas, or surfaces
Salicylic Acid 2.0%
Acne Treatment
For the treatment of acne.
For external use only
If swallowed, get medical help or contact a Poison Control Center right away.
This product contains an alpha-hydroxy acid (AHA) that may increase skin's sensitivity to the sun and particularly thepossibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using this product and for two weeks afterwards.
water, cetyl alcohol, PPG-15 stearyl ether, polyethylene, glycolic acid, glycerin, polysorbate 60, steareth-21, C12-15 alkyl lactate, tocopheryl acetate, tetrahexyldecyl ascorbate, butyrospermum parkii (shea butter), cetyl lactate, BHT, neopentyl glycol dicaprylate/dicaprate, cocamidopropyl PG-dimonium chloride phosphate, potassium cetyl phosphate, disodium EDTA, xanthan gum, sodium chloride, sodium benzotriazolyl butylphenol sulfonate, sodium hydroxide, agar, corn starch/acrylamide/sodium copolymer, menthol, benzalkonium chloride, fragrance, iron oxide, mica, red 30, red 40, yellow 5
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 37808-345 | 37808-345-73 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2489b22e-7d07-8fdb-e063-6394a90acdb4 | dfb4ab56-1161-15e1-e053-2a95a90ab85c | 2024-10-15 | Warnings | dfb4ab56-1161-15e1-e053-2a95a90ab85c |
Adverse event summaries are temporarily unavailable. Other product information remains available.